
Quadlytics Inc.
Development of medical devices and software (heart rate variability data analysis).
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | N/A | Series A | |
Total Funding | 000k |
Related Content
Quadlytics is a healthcare technology company specializing in the development of advanced algorithms for heart rate variability (HRV) analysis. Founded on February 9, 2018, as a subsidiary of Quantity Inc., the company leverages a combination of medical expertise and cutting-edge technology to create medical devices aimed at improving patient care. The core product is an app that utilizes this proprietary HRV analysis algorithm, designed to be used as a medical device by patients. The company primarily serves medical institutions and healthcare providers, operating within the global healthcare and medical device market. Quadlytics generates revenue through the sale and licensing of its medical device app to healthcare institutions and professionals. The business model focuses on continuous innovation and collaboration with medical experts to ensure the highest standards of patient care. The company's founder, Takatomi Kubuo MD, brings extensive experience in the pharmaceutical, biotechnology, and medical equipment industries, both domestically and internationally.
Keywords: HRV analysis, medical devices, healthcare technology, patient care, heart rate monitoring, medical institutions, algorithm development, healthcare providers, innovation, Takatomi Kubuo.